MPS II

Clinical trials for MPS II explained in plain language.

Never miss a new study

Get alerted when new MPS II trials appear

Sign up with your email to follow new studies for MPS II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

Hunterase extended trial shows promise for managing hunter syndrome

Disease control Completed

This study looked at the long-term safety and effectiveness of Hunterase (idursulfase beta) in 30 people with Hunter syndrome over about one year. Participants had either completed a previous phase 3 study or had used Hunterase for at least six months. The goal was to monitor sid…

Matched conditions: MPS II

Phase: PHASE3 • Sponsor: GC Biopharma Corp • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

MPS II

Get alerted when new MPS II trials appear

Hunterase extended trial shows promise for managing hunter syndrome